Due to their targeted administration and improved absorption via CD44-mediated endocytosis, HA-coated CPT NCs demonstrate dramatically improved anticancer activity when treating cancer cells that overexpress CD44.91 In addition, they have better biocompatibility and antimigration properties. Here, CD44 is linked to cancer.